Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ekeYCfbwocfbmCntzpOX

  ADVERTISEMENT  
February 12, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
  ADVERTISEMENT  
Discount on Regenerative Medicine Journal offered to AABB members
AABB has partnered with Regenerative Medicine Journal to offer an online subscription for $30 per year to AABB members. This journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine. Visit the AABB Marketplace or add-on to your online AABB membership renewal.

  Science & Health 
  • CDC: Flu season appears to be waning
    CDC officials report that in much of the U.S., flu season is starting to wind down, according to data from the week ending Feb. 2. Widespread flu activity was reported in 38 states, down from 42, and mortality attributed to influenza also was down. Nineteen states recorded high levels of flu activity, the agency said. USA Today (2/8), U.S. News & World Report (2/8) LinkedInFacebookTwitterEmail this Story
  • Aspirin plus clopidogrel lowers risk of stroke recurrence
    Researchers tracked 5,170 minor stroke or transient ischemic attack survivors in China and found that those who received aspirin and clopidogrel were 32% less likely to suffer a second stroke in 90 days than those who took aspirin alone. The two groups both had comparably low rates of intracerebral bleeding, death and myocardial infarction. The study was presented at the International Stroke Conference. MedPage Today (free registration) (2/10) LinkedInFacebookTwitterEmail this Story
 
  Emerging Trends 
  • Biosensor device offers hope of better diagnoses
    A universal biosensor could help doctors quickly identify microbes, leading to more accurate diagnoses and better treatments for illnesses. Abbott's PLEX-ID biosensor isolates microbes from saliva and blood to identify any known pathogens. The device is used for research, but a smaller version is being developed for possible use in clinical settings. New Scientist (2/6) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  • Pa. maker of placenta-derived tissue graft obtains $2.23M
    AFcell Medical has obtained $2.23 million of a targeted $10 million round, which it will use for its sales and marketing team. The Pennsylvania-based startup is the maker of AmnioClear, a tissue graft derived from the placenta of living human donors that could speed recovery for tendon surgery or wound repair patients. MedCityNews.com (2/11) LinkedInFacebookTwitterEmail this Story
The Buzz(CORPORATE ANNOUNCEMENTS)

Registration Now Open - April 9, 2013 PACT Workshop
“Developing Cellular Therapies: From Preclinical Safety to Clinical Evaluation”. Hosted by University of Wisconsin, Waisman Biomanufacturing (WB), Madison, WI. No charge for attendance. Click here for more details.


  Government & Regulatory 
  • FDA submits device data gathering proposal for OMB review
    The FDA has submitted a proposal to renew its program for gathering data about medical devices to the Office of Management and Budget for approval. The program is part of its system to identify and ban devices that are harmful or risky. The agency also is requesting public comment on its process for banning medical technologies. MassDevice.com (Boston) (2/8) LinkedInFacebookTwitterEmail this Story
  Association News 
  • AABB website features new section on malaria
    AABB's Regulatory Affairs department has created a new Web page to provide easy access to updated information on malaria. Resources to notify members of active and rescinded malaria outbreaks and recommendations, recent actions and a link to the Centers for Disease Control and Prevention also are included. Learn more. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Donor Collections DirectorBlood Centers of the PacificUS - CA - San Francisco
Medical Technologist CLS - Cord Blood ProgramSan Diego Blood BankUS - CA - San Diego
Click here to view more job listings.

  SmartQuote 
We spend our time searching for security and hate it when we get it."
--John Steinbeck,
American author


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Jennifer Garfinkel

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information